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Abstract 
Conflicts between replication and transcription challenge chromosome duplication. 
Escherichia coli replisome movement along transcribed DNA is promoted by Rep 
and UvrD accessory helicases with ∆rep ∆uvrD cells being inviable under rapid 
growth conditions. We have discovered that mutations in a tRNA gene, aspT, in an 
aminoacyl tRNA synthetase, AspRS, and in a translation factor needed for efficient 
proline-proline bond formation, EF-P, suppress ∆rep ∆uvrD lethality. Thus 
replication-transcription conflicts can be alleviated by the partial sacrifice of a 
mechanism that reduces replicative barriers, namely translating ribosomes that 
reduce RNA polymerase backtracking. Suppression depends on RelA-directed 
synthesis of (p)ppGpp, a signalling molecule that reduces replication-transcription 
conflicts, with RelA activation requiring ribosomal pausing. Levels of (p)ppGpp in 
these suppressors also correlate inversely with the need for Rho activity, an RNA 
translocase that can bind to emerging transcripts and displace transcription 
complexes. These data illustrate the fine balance between different mechanisms in 
facilitating gene expression and genome duplication and demonstrate that 
accessory helicases are a major determinant of this balance. This balance is also 
critical for other aspects of bacterial survival: the mutations identified here increase 
persistence indicating that similar mutations could arise in naturally occurring 
bacterial populations facing antibiotic challenge. 
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Introduction 
Cell survival from one generation to the next relies on efficient and faithful replication 
of the genome. However, the template for replication frequently harbors obstacles 
that have the potential to interfere with the progression of replisome complexes, the 
macromolecular machines responsible for driving genome duplication. Protein-DNA 
complexes are important sources of such obstacles and those associated with 
transcription are especially problematic, in part because of their abundance and in 
part because they present multiple different challenges to replisome movement (1-
4). One major challenge is the very high free energy of binding of transcription 
complexes that creates a need to disrupt many RNA polymerase-nucleic acid 
interactions as replication proceeds. Transcribing RNA polymerases (RNAPs) also 
pause frequently either spontaneously or upon encountering DNA template damage 
(5). Paused RNAPs can also diffuse backwards along the template resulting in 
displacement of the transcript 3' end from the RNAP active site. This causes an 
inability to resume transcription, creating barriers to replication that threaten genome 
stability (6,7). 
Mechanisms exist that reduce the probability of a replication fork encountering 
paused transcription complexes. Upstream RNAPs on the DNA and ribosomes on 
the emerging transcript may inhibit backtracking of a paused transcription complex 
in bacteria (7-9). RNA translocases such as the bacterial Rho hexamer can also 
translocate along transcripts not coated with ribosomes and displace paused and 
blocked RNAPs (7,10,11). Rho translocation also disrupts R-loops, structures in 
which an RNA transcript hybridises to the DNA template strand (11). Nucleases can 
also aid genome duplication by promoting the resumption of transcription by 
backtracked RNAP (7,12). GreA and GreB bind to E. coli RNAP and stimulate 
cleavage of backtracked transcripts, creating a new RNA 3' end that can be used to 
restart transcription (13). Conversely, the 3'-5' helicase UvrD can increase rather 
than decrease backtracking of RNAP and this may increase access of nucleotide 
excision repair enzymes UvrABC to DNA damage thus helping to clear barriers to 
RNAP and aid genome duplication (14). 
Signalling molecules such as guanosine tetraphosphate and pentaphosphate 
in bacteria (referred to collectively as (p)ppGpp) can also reprogramme 
transcription. (p)ppGpp is central to the stringent response in bacteria, identified 
originally as a response to amino acid starvation in which the presence of 
uncharged tRNA within the ribosomal A site stimulates ribosome-bound RelA to 
synthesise (p)ppGpp (15-17). Control of the stringent response also requires a 
(p)ppGpp-specific pyrophosphohydrolase, SpoT, that also has low (p)ppGpp 
synthase activity (17). However, the synthase activity of SpoT is induced by other 
stresses such as depletion of fatty acids (18). Central to the stringent response is 
binding of (p)ppGpp to RNAP which leads to downregulation of stable RNA 
production and upregulation of stress response genes (17,19,20). Expression of 
ribosomal rRNA operons accounts for half of all transcription during rapid growth 
when (p)ppGpp levels are low and thus provides the majority of transcriptional 
obstacles to replisomes in vivo when cells are dividing quickly (21-24). Elevated 
(p)ppGpp therefore reduces conflicts between replication and transcription by 
decreasing the density of transcribing RNAPs on the genome. (p)ppGpp can also 
decrease the stability of transcription complexes blocked by template damage in 
vitro which may decrease the density of blocked RNAP on the genome (12). This 
destabilisation has been questioned, though, and a role for (p)ppGpp in increasing 
the fidelity of transcription and hence reducing RNAP pausing and backtracking has 
been proposed (25). Other work implicates (p)ppGpp acting synergistically with 
UvrD in promoting backtracking of paused RNAP, one function of which could be to 
facilitate transcription-coupled repair of any pause-inducing DNA damage (26). Thus 
how (p)ppGpp might act on transcription elongation complexes, as opposed to 
transcription initiation, is still far from clear. Transcription is not the only target of 
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(p)ppGpp, though, since (p)ppGpp also binds multiple other targets. Inhibited targets 
include DnaG primase (27-30) and the translation elongation factors EFG and EF-
Tu (31), indicating the pleiotropic impact of elevated (p)ppGpp on replication, 
transcription and elongation. (p)ppGpp also affects other diverse aspects of 
metabolism such as phospholipid synthesis, oxidative metabolism and resistance to 
antibiotics (32). These signalling molecules also enhance the ability of E. coli to 
persist in the presence of antibiotics. Persistence is the non-heritable ability of a 
small fraction of a bacterial population to survive exposure to an otherwise lethal 
concentration of antibiotic (33). (p)ppGpp levels vary stochastically in a bacterial 
population and increased (p)ppGpp activates toxin-antitoxin systems that induce 
slow growth in a sub-population of cells, leading to antibiotic tolerance (34). 
Mechanisms also exist to increase the probability of continued replisome 
movement in the event of a collision with an RNAP. Accessory replicative motors 
provide a supply of additional helicases at the fork to aid protein displacement 
ahead of the replisome (35,36). In E. coli Rep helicase promotes movement of 
replisomes along protein-bound DNA in vitro and in vivo (22,37). Rep appears to be 
the main replisome anti-pausing factor in E. coli (38) and absence of Rep results in 
at least a two-fold increase in genome duplication time (39,40) and higher 
dependence on recombination-directed repair of damaged forks (41-44). However, 
∆rep cells remain viable since the homologous helicase UvrD can substitute for the 
absence of Rep at the replication fork (22,37). This substitution is only partial, 
though, and correlates with a physical and functional interaction between DnaB and 
Rep but not between DnaB and UvrD (37,45). This partial functional overlap is 
sufficient for single deletion mutants to be viable during rapid growth whereas ∆rep 
∆uvrD cells are not (46). ∆rep ∆uvrD inviability can be suppressed by growth on 
minimal medium, conditions under which (p)ppGpp levels are high, and also by 
elevation of (p)ppGpp levels on rich medium via the spoT1 mutation encoding a 
(p)ppGpp pyrophosphorylase-defective SpoT (22,37). Mutations within rpo genes 
can also suppress ∆rep ∆uvrD rich medium lethality (22,37,47). These mutant 
RNAPs display different phenotypes suggesting distinct mechanisms of suppression 
but some seem to phenocopy elevated (p)ppGpp and/or reduce RNAP backtracking 
(12,47,48). 
The above mechanisms reduce conflicts between replication and transcription 
but under rapid growth conditions forks are still blocked sufficiently frequently to 
require replisome reloading enzymes to maintain viability (49,50). Replisome 
reloading also often requires remodelling of the DNA at the blocked fork by 
recombination enzymes in order to generate a DNA structure suitable for replisome 
reloading (51). However, recombinational processing can lead to genome instability 
and is thus tightly controlled. One control is exerted by UvrD as it can disrupt RecA-
ssDNA filaments and this disruption prevents excessive RecFOR-dependent loading 
of RecA onto ssDNA at blocked forks (52). Such excessive RecA loading 
contributes to ∆rep ∆uvrD lethality, evinced by the weak suppression of ∆rep ∆uvrD 
rich medium lethality via mutations in recF, recO or recR (37,53,54). 
We have searched for suppressors of ∆rep ∆uvrD rich medium lethality that 
are not within rpo, spoT, recF, O or R. We identified a spontaneous suppressor in a 
tRNA gene, aspT[t8c], that mutated a highly conserved residue that is structurally 
important in other tRNA species. Probing the basis of this suppression revealed that 
defective tRNA aminoacylation or inefficient peptide bond formation within the 
ribosome also suppressed ∆rep ∆uvrD lethality. In all cases suppression required 
RelA-directed (p)ppGpp synthesis indicating that stalling of ribosome translocation 
by uncharged tRNA in the A site of ribosomes underpinned suppression. Thus 
although efficient translation elongation aids genome duplication (7,9), the partial 
inhibition of ribosome translocation is more effective at mitigating replication-
transcription conflicts. These data illustrate the fine balance between the multiple 
mechanisms that promote simultaneous gene expression and genome duplication 
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and reveal the importance of accessory replicative helicase activity in determining 
this balance. 
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Materials and Methods 
Plasmids and strains 
pAM403 (55) and pAM407 (37) are pRC7 derivatives encoding rep and uvrD, 
respectively. p3LC-TL30-5P and p3LC-TL30-5D contain a cadC-lacZ gene fusion in 
which five tandem codons present within the linker encode proline or aspartate, 
respectively (56). Strains were constructed by P1 vir transduction and are listed in 
Supplementary Table 1. 
 
Genome sequencing and analysis 
DNA was extracted from 1 culture each of strain N7153 and N7182 grown in LB 
broth to stationary phase using Qiagen 100/G genomic tips from 5 ml cultures 
following the manufacturer's protocol. Genome sequencing was performed using an 
Illumina GAIIx instrument with 100 bp paired end reads. Paired reads were trimmed 
to remove adapters and mapped against the E.coli K12 strain MG1655 NC_000913 
genome using bwa (57), duplicates marked using Picard 
(http://broadinstitute.github.io/picard) and variant analysis performed with SAMtools 
(58), followed by merging of variant tables using perl. Identified high quality 
synonymous and non-synonymous single nucleotide polymorphisms were annotated 
manually using the Integrative Genomics Viewer (59). The Illumina data were 
submitted in form of fastq files to the European Nucleotide Archive (ENA) and are 
available under accession number PRJEB14483 at  
http://www.ebi.ac.uk/ena/data/view/PRJEB14483. 
 
Growth assays 
All steps in plasmid loss assays were carried out at 37°C except those shown in 
Figures 2B and 3B in which all steps were conducted at 30°C or 25°C as indicated. 
Colonies were grown in LB broth and agar except the assays in Figure 2B and 
Supplementary Figures 3B and 4 which were performed with a defined rich medium 
broth and agar containing 0.2% glycerol (Figure 2B) or 0.2% glucose 
(Supplementary Figures 3B and 4) as a carbon source (60). The plates used in 
Supplementary Figures 3B and 4 also had decreasing concentrations of aspartate or 
phenylalanine, as indicated. Strains carrying derivatives of pRC7 were grown in LB 
broth or defined rich medium with 100 µg ml-1 of ampicillin overnight, diluted 100-fold 
into the same type of fresh liquid medium without ampicillin and grown to A650 0.4. 
Dilutions were then plated onto LB or defined rich medium agar plates containing 
120 µg ml-1 X-gal and 1 mM IPTG and incubated for 48 hours except those shown in 
Figure 2B. Plates were then photographed and scored for blue/white colony 
formation. 
For assays to assess colony forming ability, strains were grown in LB broth 
overnight at 37°C or, when temperature sensitive strains were involved, at 30°C. 
Serial 10-fold dilutions were made with 56/2 salts (61) on ice and then 5 µl of each 
dilution was spotted onto LB agar plates. Plates were then incubated at 37°C for 16 
hours. Ampicillin and bicyclomycin were included in LB agar plates where indicated 
at 100 and 25 μg ml-1, respectively. 
For the colony formation assays in Supplementary Figure 3A, strains were 
grown in defined rich medium broth (60) containing 0.2% glucose, all amino acids 
and 100 μg ml-1 ampicillin overnight at 37°C. Tenfold serial dilutions were made in 
56/2 salts and then 5 µl of each dilution spotted onto defined rich medium plates 
containing 0.2% glucose, 100 μg ml-1 ampicillin and with all amino acids or missing 
either aspartate or phenylalanine. These plates were incubated at 37°C for 16 
hours. Minimal medium agar plates (61) were used in Supplementary Figure 3C 
without and with 100 μg ml-1 ampicillin as indicated and incubated at 37°C for 72 
hours. 
Colony-forming ability at increasing doses of UV light was assessed as 
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described (62). Mismatch repair capacity was measured as the fraction of cells in a 
culture that acquired spontaneous mutations leading to rifampicin resistance. Briefly, 
overnight LB cultures were washed once in 56/2 salts and serially diluted tenfold. 
100 µl of the neat and the 10-1 dilution were spread on LB agar containing 15 µg ml-1 
rifampicin. To estimate the total cfu ml-1 in the overnight culture, 10 µl of the 10-6 
dilution was spotted in triplicate on LB agar without rifampicin. Plates were then 
incubated at 37°C for 16 hours and the colonies then counted. 
The liquid growth assays in Figure 2A were performed using a Tecan Infinite 
M200 Pro plate reader. Overnight LB cultures were diluted to A600 0.005 in LB and 
150 µl of each culture was transferred into 20 wells of a 96-well flat bottom plate 
(Corning). The microplate was incubated at 37°C for 24 hours and A600 
measurements were performed every 30 minutes preceded by plate shaking.  
 
Persistence 
Single colonies were inoculated into 5 ml LB broth and grown with shaking at 37°C 
overnight. 50 µl of overnight culture was then inoculated into 5 ml of LB broth and 
grown at 37°C with shaking until 1-2 x 108 colony forming units ml-1 reached. 500 µl 
was then transferred into two 1.5 ml microcentrifuge tubes. The first tube was 
centrifuged at 6000 rpm for 5 min at room temperature, resuspended in 500 µl 56/2 
salts, serially diluted tenfold in 56/2 salts and 10 µl volumes of the 10-4 and 10-5 
dilutions spotted onto LB agar plates containing 20 mM MgSO4 in triplicate. To the 
second tube 5 µl of 10 µg ml-1 ciprofloxacin was added and the tube was then 
inserted into a 50 ml Falcon tube and placed in a shaking incubator at 37°C for 5 h. 
After the 5h incubation this tube was centrifuged at 6000 rpm for 5 min at room 
temperature, resuspended in 500 µl 56/2 salts, recentrifuged and resuspended in 
500 µl 56/2 salts. Colony forming units were then assayed as for the first tube by 
serial dilution into 56/2 salts and plating in triplicate onto LB agar containing 20 mM 
MgSO4. MgSO4 was included to inhibit the activity of any traces of ciprofloxacin not 
removed by washing of the cells (63). All plates were incubated at 37°C overnight 
and then the fraction of colony forming units surviving ciprofloxacin exposure 
calculated. 
 
Flow cytometry 
Analysis of chromosome content after completion of all ongoing rounds of 
replication, so-called run-out conditions, was performed on mid-log phase cultures 
after treatment with rifampicin and cephalexin as described (64) using a Becton 
Coulter CyAn ADP cytometer with 488 nm excitation and a 530/540 nm bandpass 
filter. Analysis of (p)ppGpp-dependent formation of RpoS-mCherry by flow cytometry 
was performed by growing the indicated strains overnight in LB, transferring 100 µl 
into 10 ml LB in a 125 ml flask followed by incubation at 37°C for 2h. Then 1 ml of 
the culture was centrifuged, resuspended in 2 ml of 10% LB in M9 medium and 
analysed by flow cytometry on a Becton Dickinson LSRFortessa X-20 flow 
cytometer using  561 nm laser excitation and dection using a 610/620 nm bandpass 
filter. 
 
Translation assays 
β-galactosidase activity assays monitoring the relative levels of translation of cadC-
lacZ fusions were performed in LB broth as described (56). 
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Results 
 
A tRNA mutation suppresses the requirement for accessory replicative 
helicases 
pRC7 is a very low copy plasmid which encodes β lactamase and can therefore be 
maintained in E. coli cells by the inclusion of ampicillin in the medium (65). However, 
the inefficient origin of replication within pRC7 results in rapid loss of the plasmid in 
the absence of ampicillin. This rapid loss can be detected if the host strain has a 
chromosomal deletion of lacIZYA since pRC7 encodes the lac operon and hence 
cells with and without the plasmid appear blue and white, respectively, on plates 
containing IPTG and X-gal (65). This retention or loss of pRC7 can be used to 
assess whether a gene is essential for colony formation by cloning of the test gene 
into pRC7, transformation of a ΔlacIZYA strain with the pRC7 derivative and 
subsequent deletion of the test gene from the chromosome. Plating of the strain 
onto medium containing IPTG and X-gal results in formation of only blue colonies if 
the test gene is essential or white and segregating colonies if the test gene is not 
essential (65). Rapid growth of E. coli requires accessory helicase activity and so 
pRC7 encoding uvrD can be lost rapidly from  ∆lacIZYA rep+ uvrD+ cells on rich 
medium but pRC7uvrD cannot be lost from ∆lacIZYA ∆rep ∆uvrD cells as monitored 
by blue/white colony colour (37) (see also Figure 1A, compare i and ii). 
Spontaneous mutations that suppress this requirement for an accessory helicase 
can be isolated by exploiting the ability of ∆rep ∆uvrD cells to grow on minimal 
medium in the absence of a complementing pRC7 plasmid and subsequent plating 
of plasmid-less cells onto rich medium (37). Rare survivors on rich medium can then 
form colonies and the mutation(s) responsible for allowing ∆rep ∆uvrD cells to grow 
under rapid growth conditions can be analysed. We identified one such suppressor, 
the strain designation of which is N7182 (Supplementary Table 1). Potential linkage 
of the suppressor mutation to rep was tested by transducing ∆rep::cat from the 
suppressor strain into pRC7uvrD/rep+ ∆uvrD::dhfr (N6639). Eleven chloramphenicol-
resistant transductants were tested for loss of pRC7uvrD on rich medium. Four 
transductants could not lose pRC7uvrD but seven could, indicating close linkage of 
the suppressor mutation with ∆rep::cat (see also Figure 1A, compare ii and iii). 
We sequenced the genome of this suppressor strain and compared it with the 
genome of N7153, a ∆rep ∆uvrD strain that contains a well-characterised 
suppressor mutation rpoB*35 (7,12,37,66). Use of the ∆rep ∆uvrD rpoB*35 strain as 
a reference genome avoided the need for the reference strain to retain a 
complementing plasmid for viability. Only one mutation in N7182 that was not 
present in N7153 was located sufficiently close to ∆rep::cat to explain the above 
linkage (see Supplementary File 1). This mutation resulted in replacement of T with 
C at position 8 within the aspT gene, one of three identical tRNAAsp genes in E. coli. 
Sequencing of the aspT gene from the 11 transductants obtained in the above cross 
revealed that all seven strains able to lose pRC7uvrD contained aspT[t8c] whereas 
all four that could not lose pRC7uvrD retained a wild type copy of aspT. Suppression 
of the inviability of ∆rep ∆uvrD cells on rich medium was therefore associated with 
the aspT[t8c] allele, with suppression comparable to that of rpoB*35 in a plasmid 
loss assay (Fig 1A, compare iii and iv). 
∆rep uvrD+ cells have a growth defect defect since UvrD can compensate only 
partially for the absence of Rep accessory helicase activity, resulting in slower 
movement of replication forks in ∆rep cells (39,40). Thus the median number of 
copies of oriC in ∆rep uvrD+ cells is twice that of rep+ uvrD+ cells in rich medium due 
to an extended cell cycle in ∆rep cells and hence more replication initiation events 
per cell cycle (38). This doubling in oriC numbers results in a doubling of 
chromosome content when cells are treated with cephalexin and rifampicin to inhibit 
cell division and reinitiation of replication, so-called run-out conditions (38) (see also 
Figure 1B, compare i and iii). aspT[t8c] suppressed the increased chromosome copy 
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number in ∆rep uvrD+ cells, reducing the median number of chromosomes from 
eight to four (Figure 1B, compare iii and iv). These data support the conclusion that 
this tRNA mutation reduces the need for accessory helicase activity. Furthermore, 
aspT[t8c] had no detectable impact on other UvrD-mediated processes. Defects in 
nucleotide excision repair, mismatch repair and control of recombination in rep+ 
∆uvrD cells (52,67,68) were not suppressed by aspT[t8c] (Supplementary Figure 1A, 
B and C, respectively), providing further support for the specific suppression of the 
accessory helicase defect in ∆rep ∆uvrD cells by aspT[t8c]. 
The requirement for accessory helicase activity is driven primarily by 
transcriptional barriers to replication (22,37). Backtracking of paused RNA 
polymerases results in formation of particularly stable replicative barriers and 
multiple factors have evolved to reduce the numbers of backtracked complexes (7). 
Cells lacking two homologous anti-backtracking factors, GreA and GreB, display a 
temperature-sensitive growth defect that is a consequence of more frequent 
collisions between replisomes and backtracked transcription complexes (7,12,69). 
aspT[t8c] suppressed the temperature-sensitive phenotype of ∆greA ∆greB cells 
(Figure 1C), similar to the suppression seen with rpoB*35 (48). We conclude that 
aspT[t8c] reduces the need for GreA/GreB-dependent rescue of backtracked RNA 
polymerase. 
Taken together, these data indicate that aspT[t8c] reduces the need for Rep 
and UvrD to underpin replication and for anti-backtracking factors to resuscitate 
transcription complexes. 
 
Suppression by aspT[t8c] does not occur via growth rate restriction 
The uridine encoded at position 8 within the wild type aspT gene is post-
transcriptionally modified to 4-thiouridine and this modified nucleotide is conserved 
across all kingdoms of life (70). This residue is involved in a triple non-Watson-Crick 
pairing interaction and is important in coordination of magnesium within tRNA 
(71,72). This central structural role is reflected in the temperature-dependent 
destabilisation of human mitochondrial tRNAMet structure by the same T to C 
mutation as found in aspT[t8c]. This transition mutation in tRNAMet inhibits 
aminoacylation and any mutated tRNAMet that is aminoacylated fails to form a stable 
ternary complex with elongation factor EF-Tu (70). 
Given the conservation of tRNA structure, aspT[t8c] may result in similar 
structural destabilisation of the encoded tRNAAsp and consequent inhibition of 
interactions with aspartyl tRNA synthetase and EF-Tu. However, aspT[t8c] did not 
have a major impact on growth of rep+ uvrD+ cells in liquid culture (Figure 2A, 
compare i and ii). This absence of a significant growth defect in aspT[t8c] strains 
may be due to the presence of two other identical tRNAAsp genes in E. coli, aspU 
and aspV. 
Other means of growth restriction did not suppress ∆rep ∆uvrD inviability. Growth 
on defined rich medium containing all 20 amino acids but with a poor carbon source, 
glycerol, did not result in suppression of ∆rep ∆uvrD aspT+ inviability at either 37°C 
or 25°C as determined using a plasmid loss assay (Figure 2B). Reduced growth 
rates therefore do not provide a general means of reducing the need for accessory 
helicase activity. 
 
Defective tRNA aminoacylation suppresses ∆rep ∆uvrD inviability 
 As reduced growth rate was not the cause of suppression by aspT[t8c], we  
probed whether defective translation was responsible. We could not detect significant 
defects in translation in vivo at tandem aspartate codons in an aspT[t8c] strain 
(Supplementary Figure 2). Either this allele does not result in translational pausing or 
such pausing is below the limits of detection using this assay. We therefore used 
alternative approaches to probe the aspT[t8c] suppression mechanism. The same 
t8c mutation in human mitochondrial tRNAMet inhibits aminoacylation (70). Inhibition 
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of tRNAAsp aminoacylation was therefore tested for suppression of ∆rep ∆uvrD 
lethality. The E. coli tls-1 allele encodes a P555S mutation in aspartyl tRNA 
synthetase that reduces the thermal stability of the synthetase and causes a severe 
reduction in growth rate at 42°C under low salt conditions (73,74) (see also Figure 
3A). Given that AspRSP555S is less stable than wild type enzyme regardless of the 
temperature (74), we tested whether aspSP555S suppressed ∆rep ∆uvrD lethality at 
30°C on low salt medium, conditions under which viability is similar to wild type (73) 
(see also Figure 3A, compare i and ii). pRC7uvrD could be lost from ∆rep ∆uvrD 
aspSP555S at 30°C on low salt medium but not on high salt medium (Figure 3Biii). 
Suppression of ∆rep ∆uvrD lethality correlates therefore with a defect in aspartyl 
tRNA synthetase. 
We also tested whether an alternative means of inhibiting tRNAAsp 
aminoacylation could suppress ∆rep ∆uvrD inviability. A pRC7uvrD/∆rep ∆uvrD strain 
defective in aspartate biosynthesis could lose the complementing pRC7uvrD plasmid 
on defined rich medium upon restriction of aspartate availability (Supplementary 
Figure 3). Thus a defect in the enzyme needed to synthesise aspartyl tRNA, AspRS, 
or a limiting concentration of one of the substrates needed for formation of aspartyl 
tRNA, aspartate, can suppress the need for accessory replicative helicase activity. 
Moreover, suppression was not specific to aspartate starvation as restriction of 
availability of phenylalanine also allowed ∆rep ∆uvrD cells to survive in the absence 
of a complementing plasmid (Supplementary Figure 4). As expected, restricting 
amino acid availability also resulted in very poor growth (Supplementary Figures 3 
and 4) but a restricted growth rate does not by itself provide suppression of ∆rep 
∆uvrD lethality (Figure 2B). These data support the conclusion that inhibition of 
aminoacylation of tRNAAsp, and of other tRNAs, reduces the need for accessory 
helicase activity. 
 
Translational pausing suppresses ∆rep ∆uvrD inviability 
Suppression of ∆rep ∆uvrD inviability via inhibition of tRNAAsp or tRNAPhe 
aminoacylation might occur directly via pausing of ribosomes but could also occur via 
decreased production of one or more specific proteins containing both aspartate and 
phenylalanine. We tested therefore whether increased translational pausing by a 
well-defined mechanism that does not rely on decreased tRNA aminoacylation also 
suppresses the need for accessory helicase activity. Peptide bond formation by 
ribosomes occurs with low efficiency within polyproline tracts as compared with other 
amino acids and this low efficiency is compensated for by interaction of elongation 
factor P (EF-P) with the ribosome (56,75). When EF-P is absent (∆efp) ribosomes 
pause for extended periods at tandem proline codons (56,75) (see also 
Supplementary Figure 2) resulting in reduced growth rates (76) (see also Figure 2A). 
Despite its negative effect on growth rate, introduction of ∆efp clearly suppresses 
∆rep ∆uvrD lethality (Figure 4, compare A and B). yjeA and yjeK encode enzymes 
needed for post-translational modification of EF-P to form fully functional enzyme 
(56,75-78) and deletion of either yjeA or yjeK also resulted in suppression (Figure 4C 
and D). Enhancement of ribosomal pausing at polyproline sequences can therefore 
reduce the need for accessory helicase activity.  
 
Suppression by aspT[t8c] and ∆efp requires (p)ppGpp synthesis 
One consequence of ribosomal pausing is increased synthesis of (p)ppGpp by RelA 
upon binding of RelA to a ribosome containing a non-acylated tRNA in the A site 
(15,16). Elevated (p)ppGpp is known to suppress ∆rep ∆uvrD inviability (37) and so 
aspT[t8c] and ∆efp might both therefore suppress via elevation of (p)ppGpp 
concentration. 
Direct measurement of (p)ppGpp using 32P cannot be performed on cells grown 
in rich media (79) which prevents direct assessment of (p)ppGpp levels in aspT[t8c] 
and ∆efp strains under conditions relevant to suppression of ∆rep ∆uvrD lethality. An 
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indirect assay was therefore used that employs an RpoS-mCherry translational 
fusion (34). This reporter provides a fluorescence signal that correlates with 
intracellular (p)ppGpp concentration due to (p)ppGpp both stimulating rpoS 
transcription and inhibiting RpoS degradation (34). Fluorescence was assayed by 
flow cytometry of cells grown to mid-logarithmic phase in rich medium. relA+ spoT+ 
cells lacking the RpoS-mCherry fusion and rpoS-mCherry ∆relA ∆spoT cells which 
are unable to synthesise (p)ppGpp gave similar levels of background fluorescence 
(Figure 5Ai and ii). An increase in fluorescence was observed in wild type cells 
carrying the fusion but this increase was modest (Figure 5A, compare iii with i and ii), 
consonant with low (p)ppGpp levels in wild type cells growing in nutrient-rich 
environments (34,80). mCherry fluorescence increased substantially in ∆efp cells but 
not in aspT[t8c] cells with respect to wild type (Figure 5A, compare iv and v with iii). 
We conclude that absence of EF-P results in elevation of (p)ppGpp concentration. 
Higher (p)ppGpp concentration in ∆efp cells as compared with wild type or aspT[t8c] 
cells is consistent with the significant retardation of growth of ∆efp cells (Figure 2A). 
In contrast, aspT[t8c] either does not increase (p)ppGpp levels as compared with wild 
type cells or any increase is below the limits of detection using this assay. To gauge 
the sensitivity of this assay we monitored fluorescence in spoT1 cells. spoT1 
encodes a SpoT enzyme that retains (p)ppGpp synthase activity but lacks (p)ppGpp 
pyrophosphorylase activity, resulting in elevated (p)ppGpp (81) and the ability to 
suppress ∆rep ∆uvrD lethality (37). spoT1 rpoS-mCherry cells did not result in 
increased fluorescence as compared with spoT+ rpoS-mCherry cells indicating that 
(p)ppGpp levels sufficient to reduce the need for accessory replicative helicases 
could go undetected using this assay (Figure 5Aiii and vi). 
To address this potential sensitivity problem we employed a second assay to 
determine whether either ∆efp or aspT[t8c] results in elevated (p)ppGpp. Cells with 
elevated (p)ppGpp display elevated levels of persistence and thus spoT1 enhances 
whereas ∆relA ∆spoT alleles reduce persistence (34,82) (see also Figure 5Bi-iii). 
aspT[t8c] and ∆efp both increased persistence with the increase being higher for 
∆efp (Figure 5Biv and v). The large increase in persistence in ∆efp cells correlates 
with the enhancement of fluorescence in ∆efp rpoS-mCherry cells. The level of 
persistence in aspT[t8c] cells is consistent with a smaller increase in (p)ppGpp levels 
as compared with ∆efp that is below the limits of detection in the mCherry 
fluorescence assay. 
We tested whether increased (p)ppGpp contributed to suppression of ∆rep 
∆uvrD inviability by aspT[t8c] and ∆efp by deleting the gene encoding the primary 
(p)ppGpp synthase, relA. Deletion of relA prevented loss of pRC7uvrD from ∆rep 
∆uvrD aspT[t8c] and ∆rep ∆uvrD ∆efp cells, indicating that RelA was required for 
suppression by both mutant alleles (Figure 5C, compare iii with iv and v with vi). In 
contrast, pRC7uvrD could be lost from ∆rep ∆uvrD ∆relA rpoB*35 cells indicating that 
RelA was not required for the viability of suppressed ∆rep ∆uvrD strains under all 
circumstances (Figure 5C, compare vii and viii). This lack of dependence of ∆rep 
∆uvrD rpoB*35 on RelA likely reflects the recapitulation by rpoB*35 of many 
phenotypes associated with elevated (p)ppGpp even in the absence of RelA (48,66).  
Taken together, these data indicate that RelA-directed synthesis of (p)ppGpp is 
important for suppression of ∆rep ∆uvrD lethality by both aspT[t8c] and ∆efp. 
 
aspT[t8c] and ∆efp confer differing requirements for Rho activity 
Translocation 5'-3' by Rho along untranslated and unstructured nascent transcripts 
can displace transcription complexes thus reducing both RNA polymerase occupancy 
on the chromosome and R-loop formation (11,83,84). Rep and Rho therefore provide 
two different mechanisms that reduce the impact of transcription on replication. 
Consequently, cells need either Rep or wild type levels of Rho activity to maintain 
genome duplication in the face of transcriptional barriers (10,85). One manifestation 
of this requirement is the hypersensitivity of ∆rep uvrD+ cells to low concentrations of 
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the Rho-specific inhibitor bicyclomycin (10) (see also Figure 6A and B, compare i and 
iii). 
We assessed whether ∆efp or aspT[t8c] could suppress ∆rep bicyclomycin 
hypersensitivity. Neither ∆efp nor aspT[t8c] altered bicyclomycin sensitivity in a rep+ 
background (Figure 6A and B, compare i and ii). In ∆rep cells hypersensitivity was 
suppressed by ∆efp but not by aspT[t8c] (Figure 6A and B, compare iii and iv). These 
data demonstrate that ∆efp but not aspT[t8c] can reduce the requirement for Rho 
activity in the absence of Rep. 
We also tested whether this differential need for Rho activity was reflected in 
cells lacking both rep and uvrD by exploiting rho[A243E] which encodes a partial loss 
of function enzyme (86). Rho dependency was assessed by the ability of ∆rep ∆uvrD 
strains to lose a complementing pRC7rep rather than pRC7uvrD plasmid, allowing 
construction of pRC7rep/∆rep ∆uvrD rho[A243E] strains regardless of rep rho double 
mutant lethality (85). The similar numbers and sizes of white plasmidless colonies 
formed by ∆rep ∆uvrD ∆efp rho+ and ∆rep ∆uvrD ∆efp rho[A243E] cells indicate that 
wild type Rho function was not required for suppression by ∆efp (Figure 6C, compare 
v and vi). In contrast, ∆rep ∆uvrD aspT[t8c] rho[A243E] gave much smaller white 
plasmidless colonies as compared with the isogenic rho+ strain indicating that wild 
type Rho function was important for growth of aspT[t8c] ∆rep ∆uvrD cells (Figure 6C, 
compare iii and iv). 
The data in Figures 5 and 6 indicate that the viability of aspT[t8c] ∆rep ∆uvrD 
cells requires both the major (p)ppGpp synthase in the cell, RelA, and wild type Rho 
activity. In contrast, ∆efp ∆rep ∆uvrD cells require RelA but not wild type Rho activity. 
∆efp cells have higher levels of (p)ppGpp as compared with aspT[t8c] (Figure 5A) 
and these elevated levels might explain the differential requirement for Rho, given 
the ability of (p)ppGpp to reduce replication/transcription conflicts (12,37,66). Such a 
model implies that (p)ppGpp synthesis is critical not only for the viability of ∆efp ∆rep 
∆uvrD cells (Figure 5C) but also for suppression of bicyclomycin sensitivity of ∆rep 
cells (Figure 6A). Absence of the primary (p)ppGpp synthase RelA did not 
hypersensitise otherwise wild type cells to bicyclomycin (Figure 7Aiii). However, the 
suppression of ∆rep bicyclomycin hypersensitivity by ∆efp was abolished upon 
deletion of relA (Figure 7A, compare viii with v). Thus RelA-dependent (p)ppGpp 
synthesis in ∆rep ∆efp cells is essential for survival with lowered Rho activity, 
supporting the hypothesis that elevated (p)ppGpp can reduce the need for Rho. 
We tested this possible link between (p)ppGpp concentration and requirement 
for Rho by determining whether other means of increasing (p)ppGpp concentration 
can reduce the need for Rho activity in ∆rep cells. The spoT1 allele suppressed ∆rep 
bicyclomycin hypersensitivity supporting the conclusion that elevated (p)ppGpp can 
reduce the need for Rho (Figure 7B, compare iv with ii). 
The data in Figures 5-7 indicate that both aspT[t8c] and ∆efp require RelA-
directed synthesis of (p)ppGpp to maintain the viability of ∆rep ∆uvrD cells. In 
contrast, ∆efp has a much lower dependence on Rho activity as compared with 
aspT[t8c]. This differential requirement for Rho activity correlates with higher 
(p)ppGpp levels in ∆efp cells as compared with aspT[t8c]. Resolving conflicts 
between replication and transcription involves therefore a fine balance between 
accessory replicative helicases, levels of (p)ppGpp and Rho activity. 
 
Discussion 
We have discovered three new types of suppressors of ∆rep ∆uvrD rich medium 
lethality: mutations in tRNA genes, in aminoacyl-tRNA synthetases and in translation 
elongation factors. Whilst the mechanistic consequences of the aspT[t8c] mutation 
are unclear, the inhibition of tRNA aminoacylation by aspSP555S and of translation 
elongation by ∆efp are well-characterised (56,74,75), indicating that partial inhibition 
of translation can suppress ∆rep ∆uvrD lethality. Previous studies have 
demonstrated that this lethality is caused primarily by the conflict between 
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replication and transcription (22,37,54). Thus partial inhibition of translation can 
compensate for the impact of transcription on DNA replication in the absence of Rep 
and UvrD. Suppression requires RelA-directed synthesis of (p)ppGpp with (p)ppGpp 
concentration being higher with ∆efp than with aspT[t8c] (Figure 5). Wild type levels 
of Rho activity are also needed in aspT[t8c] ∆rep ∆uvrD but not ∆efp ∆rep ∆uvrD 
cells indicating that the relative importance of (p)ppGpp and Rho function depends 
upon the nature of the translational mutation (Figure 6). 
∆rep ∆uvrD cells are inviable on rich medium primarily because of lack of 
accessory replicative helicase function (22,37,54). Suppression of this growth defect 
by the above translation mutations (Figures 1A, 3B and 4) therefore suggest that it is 
the lack of accessory helicase activity in ∆rep ∆uvrD cells that is being suppressed. 
Suppression by aspT[t8c] of the chromosome content defect of ∆rep cells, a direct 
consequence of slower fork movement in the absence of Rep accessory helicase 
activity (37-39), supports this view (Figure 1B). UvrD also inhibits RecFOR-
dependent loading of RecA at blocked replication forks (52,68) and absence of this 
function makes a minor contribution to ∆rep ∆uvrD lethality (22,37,53). However, the 
lack of suppression of this RecA displacement defect by aspT[t8c] (Supplementary 
Figure 1C) indicates that suppression of ∆rep ∆uvrD lethality by aspT[t8c] does not 
operate via an effect on RecA loading. UvrD might also aid replication of transcribed 
DNA by inducing backtracking of RNAP stalled at DNA lesions, one consequence of 
which may be to promote repair of the lesion and allow the RNAP to then continue 
transcription (14). However, ∆rep ∆uvrA cells, lacking nucleotide excision repair, are 
viable (54) indicating that lesion repair via UvrD-catalysed backtracking of RNAP 
cannot be a major contributor to ∆rep ∆uvrD lethality. aspT[t8c] also does not 
suppress the sensitivity of ∆uvrD cells to UV light indicating that aspT[t8c] does not 
suppress nucleotide excision repair defects (Supplementary Figure 1A). 
Furthermore, aspT[t8c] suppression of the ∆greA ∆greB growth defect indicates that 
aspT[t8c] can suppress the absence of an anti-backtracking activity, making it 
difficult to explain how aspT[t8c] could also suppress the absence of a UvrD pro-
backtracking function (Figure 1C). 
RelA-directed synthesis of (p)ppGpp plays a central role in maintaining ∆rep 
∆uvrD viability by aspT[t8c] and by ∆efp (Figure 5C). (p)ppGpp dramatically inhibits 
transcription of rrn operons (19) which are the primary transcriptional barriers to 
genome duplication (21,24), together with other highly expressed operons (20). 
(p)ppGpp may also destabilise stalled RNAP (12) or increase the fidelity of 
transcription (25), both of which could decrease the impact of transcription on fork 
movement. aspT[t8c]- and ∆efp-directed suppression of ∆rep ∆uvrD lethality via 
(p)ppGpp is therefore likely to occur by impacting on transcription initiation, stalled 
RNAP stability and/or decreased pausing due to enhanced fidelity. 
RelA is stimulated to synthesise (p)ppGpp when an uncharged cognate tRNA 
is bound to the ribosomal A site (15,16). aspT[t8c] and ∆efp mutations may therefore 
increase the probability of A site-bound uncharged tRNA either directly or indirectly. 
The uridine at position 8 is highly conserved in tRNA species and the equivalent t8c 
mutation within human mitochondrial tRNAMet results in inhibition of tRNA 
aminoacylation (70). If aspT[t8c] also resulted in inhibition of aminoacylation then 
the resulting increase in non-acylated tRNAAsp could lead to an increased probability 
of uncharged tRNAAsp occupying the ribosomal A site. However, whether the mutant 
tRNAAsp can still bind to the A site is unknown. Alternatively tRNAasp[t8c] might poison 
the aspartyl tRNA synthetase by binding to it and forming a dead end complex with 
respect to aminoacylation. Formation of such a dead end complex might titrate out 
aspartyl tRNA synthetase and increase levels of uncharged wild type tRNAAsp 
leading to increased non-acylated tRNAAsp occupying the ribosomal A site. For cells 
lacking EF-P, YjeA or YjeK it is difficult to conceive how a reduced rate of proline-
proline bond formation within the ribosome could lead directly to increased 
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occupancy of the A site by uncharged tRNA. Absence of any one of these three 
factors, though, does impact on expression of many genes and so altered 
expression of one or more genes in ∆efp, ∆yjeA or ∆yjeK cells could result in an 
increased probability of A site-bound uncharged tRNA. For example, ∆efp cells have 
reduced expression of valyl tRNA synthetase (87) which could lead to accumulation 
of uncharged tRNAVal and triggering of the stringent response. Suppression of ∆rep 
∆uvrD lethality by aspSP555S demonstrates that suppression via partial loss of tRNA 
synthetase function can occur (Figure 3). 
In contrast to the requirement for RelA to sustain suppression of ∆rep ∆uvrD 
lethality by both aspT[t8c] and ∆efp, the requirement for Rho activity is reduced in 
∆efp as compared with aspT[t8c] cells (Figures 6 and 7). This difference correlates 
with the higher concentration of (p)ppGpp in ∆efp as compared with aspT[t8c] cells 
(Figure 5). A role for (p)ppGpp in reducing the need for Rho activity is supported by 
the ability of spoT1 to suppress ∆rep bicyclomycin hypersensitivity (Figure 7B). 
Suppression of ∆rep bicyclomycin hypersensitivity by ∆efp also depends on RelA 
which supports a critical balance between (p)ppGpp concentration and Rho activity 
in maintaining viability (Figure 7A). Elevated (p)ppGpp can therefore reduce the 
need for Rho. 
The greater dependence of aspT[t8c]-directed suppression on Rho might 
reflect not just lower (p)ppGpp levels in aspT[t8c] versus ∆efp cells but possibly also 
enhancement of Rho binding on nascent transcripts by aspT[t8c]. In other words, 
suppression via aspT[t8c] might occur at least partly via the increased generation of 
Rho binding sites on emerging transcripts. Aspartate codons are more frequent than 
polyproline tracts and hence aspT[t8c] has the potential to impact on ribosome 
translocation more frequently than ∆efp. Enhancement of Rho binding would also be 
dependent only on ribosomal pausing and not specifically require ribosomal A site 
occupancy by a non-aminoacylated tRNA (88), in contrast to stimulation of RelA 
activity (15,16). However, any aspT[t8c]-directed increase of transcription complex 
displacement by Rho cannot be sufficient by itself to suppress ∆rep ∆uvrD lethality 
since RelA is also needed (Figure 5C). 
Our data indicate that whilst translation helps prevent RNAP backtracking (7,9) 
the reduction of conflicts between replication and transcription can be achieved 
more effectively by partial inhibition of translation. Of course, the growth defect in 
∆efp cells (Figure 2A) indicates why the balance between replication, transcription, 
translation and (p)ppGpp synthesis is poised as it is in wild type cells. Thus for the 
maintenance of rapid growth there is a very fine balance to be struck between gene 
expression and accurate, rapid genome duplication. Furthermore, accessory 
replicative helicases play a major role in determining this balance. In the absence of 
both Rep and UvrD the wild type balance between various other mechanisms that 
reduce the impact of transcription on replication is unable to effectively counter the 
adverse effects of transcription on completion of genome duplication. There may 
also be circumstances under which mutations such as those identified here confer a 
selective advantage even in rep+ uvrD+ cells. Elevated (p)ppGpp is a key factor in 
determining bacterial persistence in the face of antibiotic challenge (34) and both 
aspT[t8c] and ∆efp mutations enhance persistence (Figure 5B). It remains possible 
therefore that mutations such as aspT[t8c] that have only a modest inhibitory effect 
on growth could arise in bacterial populations continually exposed to antibiotics, 
especially given the many mutations known to affect translation (89). Increased 
persistence in strains lacking EF-P function also imply that EF-P and its unique post-
translational modification pathway are poor potential targets for antibiotics. 
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Figure Legends 
Figure 1. A mutation in an aspartyl tRNA gene suppresses the need for accessory 
replicative helicases and for anti-backtracking factors. 
(A) Retention or loss of pRC7uvrD (pAM407) from strains without or with ∆rep ∆uvrD 
deletions as judged by blue/white colony colour on LB plates containing X-gal and 
IPTG. Fractions of white colonies are indicated below each image with actual 
numbers of white versus total colonies counted in parentheses. 
(B) DNA content of the indicated strains as monitored by flow cytometry under run 
out conditions in LB. The number of chromosome equivalents per cell is shown 
below. 
(C) The viability of greA+ greB+ versus ∆greA ∆greB cells without and with aspT[t8c] 
as monitored by serial dilutions of liquid cultures grown at 30°C and plated 
subsequently on LB agar at 30°C and 42°C. 
 
Figure 2. The impact of aspT[t8c] on growth and its relevance to ∆rep ∆uvrD 
inviability. 
(A) Growth of (i) aspT+ efp+ (TB28), (ii) aspT[t8c] efp+ (KM231) and (iii) aspT+ ∆efp 
(MH299) in LB at 37oC as monitored by absorbance at 600 nm. 
(B) Assessment  of the ability of pRC7uvrD (pAM407) to be lost from ∆rep ∆uvrD 
cells by reducing growth rates via culturing at 37oC and 25oC for the indicated times 
on defined rich medium containing glycerol as a carbon source. 
 
Figure 3. A mutation in aspartyl tRNA synthetase suppresses ∆rep ∆uvrD lethality. 
(A) The indicated strains were grown overnight in high salt medium at 30°C and then 
serial dilutions plated onto low and high salt plates containing 100 μg ml-1 ampicillin 
and incubated at either 30°C or 42°C. 
(B) Suppression of ∆rep ∆uvrD lethality by aspSP555S on rich medium was analysed 
by monitoring retention or loss of pRC7uvrD (pAM407) from the indicated strains at 
30°C on either low or high salt LB medium. 
 
Figure 4. Ribosomal pausing decreases the requirement for accessory helicase 
activity. 
Retention or loss of pRC7rep (pAM403) was monitored at 37°C on LB X-gal IPTG 
plates for the indicated strains. 
 
Figure 5. (p)ppGpp synthesis is needed for suppression of ∆rep ∆uvrD lethality by 
aspT[t8c] and ∆efp. 
(A) Flow cytometric detection of in vivo levels of RpoS-mCherry fluorescence in the 
indicated strains. All strains contain the rpoS-mCherry fusion with the exception of (i) 
MG1655. 
(B) Survival after challenge with ciprofloxacin. The strains are (i) TB28, (ii) KM241, 
(iii) N5777, (iv) KM231 and (v) MH372. 
(C) Retention and loss of pRC7uvrD (pAM407) on LB X-gal IPTG agar in relA+ and 
∆relA strains. 
 
Figure 6. ∆efp but not aspT[t8c] can bypass the need for wild type Rho activity. 
(A) and (B) The indicated strains were grown in liquid culture in the absence of 
bicyclomycin and their ability to continue to divide with reduced Rho activity was 
assessed after serial dilution onto plates without and with 25 µg ml-1 bicyclomycin. 
(C) Loss of pRC7rep (pAM403) on LB X-gal IPTG agar in rho+ (i, iii, v) and 
rho[A243E] (ii, iv, vi) strains. 
 
Figure 7. The ability of ∆efp to bypass the requirement for wild type Rho activity is 
dependent on (p)ppGpp synthesis. 
(A) and (B) Strains were grown in the absence of bicyclomycin and then serial 
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dilutions were plated onto LB agar without and with 25 µg ml-1 bicyclomycin. 
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Supplementary Information 
 
 
 
Supplementary Figure 1. aspT[t8c] does not suppress defects in nucleotide excision 
repair, mismatch repair or control of recombination in ΔuvrD cells. 
(A) Nucleotide excision repair. The ability of the indicated strains to survive exposure 
to DNA damage was assessed at increasing doses of 254 nm UV light. ΔuvrD cells 
were sensitive to UV light as compared with uvrD+ and this sensitivity was not 
suppressed by aspT[t8c] (compare KM235 and 237). 
(B) Mismatch repair. The accumulation of rifampicin-resistant spontaneous mutations 
upon growth of a single colony to stationary phase in liquid culture was used as a 
readout of mismatch repair. The strains were those used in panel (A). ΔuvrD cells 
gave rise to more rifampicin resistant colonies as compared with uvrD+ but this defect 
in mismatch repair was not suppressed by aspT[t8c]. 
(C) Control of recombination. UvrD modulates levels of homologous recombination by 
displacing RecA from DNA (1). When RecA-directed strand exchange does proceed 
then RuvABC resolves any Holliday junctions formed thus facilitating chromosome 
segregation by removing interchromosomal Holliday junctions (2). Thus UvrD inhibits 
formation of interchromosomal Holliday junctions whilst RuvABC resolves such 
junctions when they do form. Efficient chromosome segregation requires either UvrD 
or RuvABC in recA+ cells, evinced by the very low viability of ΔuvrD ΔruvABC cells (2). 
Thus pRC7uvrD can be lost from uvrD+ ΔruvABC cells on LB agar at high frequency 
with no significant impact on plasmidless white colony size whereas plasmidless 
ΔuvrD ΔruvABC colonies are very small, indicative of a severe viability problem 
(compare i with iii). This viability problem was not suppressed by aspT[t8c] (compare 
iii and iv). 
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Supplementary Figure 2. aspT[t8c] does not cause significant pausing of ribosomes 
at aspartate codons. 
(A) Schematic of the gene fusion cassette used to assess the relative impact of 
codons on efficiency of translation (3). The first 30 codons of cadC are fused in frame 
with lacZ via a linker sequence that encodes five consecutive aspartate or proline 
codons. β-galactosidase assays are then used with transformed E. coli cells to 
determine the impact of the repeated aspartate and proline codons on LacZ levels, 
providing a readout of translational efficiency. 
(B) (i) YjeA, YjeK and EF-P are all needed for efficient translation of polyproline 
sequences and, as expected, levels of translation of the lacZ fusion protein from a 
plasmid containing five proline codons (p3LC-TL30-5P) (3) are inhibited when any one 
of these factors is absent as compared with a wild type strain. (ii) In contrast, the 
aspT[t8c] mutation does not result in significant inhibition of translation of lacZ from 
the plasmid encoding five tandem aspartate codons (p3LC-TL30-5D) as indicated by 
the similar levels of β-galactosidase activity in wild type and aspT[t8c] strains. 
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Supplementary Figure 3. Restriction of aspartate availability suppresses Δrep ΔuvrD 
lethality. 
(A) Aspartate auxotrophy requires mutations in both aspartate aminotransferase and 
aromatic amino acid aminotransferase, encoded by aspC and tyrB respectively, since 
each can catalyse the transamination of oxaloacetate from glutamate to form 
aspartate (4,5). Both these aminotransferases can also catalyse the final step in 
phenylalanine biosynthesis but aspC tyrB strains still synthesise phenylalanine since 
the branched chain amino acid aminotransferase encoded by ilvE can catalyse this 
reaction to a limited extent (4,6). We introduced both aspC and tyrB deletions into 
pRC7uvrD/Δrep ΔuvrD. This strain (ii) could grow on defined rich medium when all 
amino acids were provided, although colony sizes were reduced. Absence of 
aspartate or phenylalanine exacerbated this growth defect severely but weak growth 
was still observable. Restricted growth was expected in the absence of phenylalanine 
via the ilvE-encoded branched chain amino acid aminotransferase (4,6). However, the 
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limited growth in the absence of added aspartate suggests that trace amounts of 
aspartate were present in preparations of the other amino acids present in the defined 
medium. 
(B) Retention or loss of pRC7uvrD was monitored for the indicated strains on defined 
rich medium with decreasing concentrations of added aspartate. Absence of added 
aspartate had no significant impact on colony sizes or on frequency of loss of 
pRC7uvrD for either (i) JA012 or (ii) N6644, as expected since both strains retain the 
aspC and tyrB genes but colony sizes for (iii) KM011 decreased with decreasing 
aspartate concentration. Very small KM011 colonies could still form in the absence of 
added aspartate, consonant with the very restricted growth seen in (Aii), and some of 
these colonies were white indicating loss of pRC7uvrD. Limiting the availability of 
aspartate therefore suppresses Δrep ΔuvrD lethality. 
(C) Loss of pRC7uvrD from KM011 in the absence of added aspartate (see Biii) was 
confirmed by using ampicillin resistance as a marker for the presence or absence of 
pRC7uvrD which encodes β lactamase. Two white [W] and two blue [B] colonies of 
KM011 and JA012 from the 0 µM aspartate plates in (B) were resuspended in 100 µL 
56/2 salts solution, serially diluted in the same salts solution and 5 µL of the 100-10-5 
dilutions spotted onto minimal medium plates containing glucose and all amino acids 
without and with ampicillin. All dilutions of resuspended blue colonies gave colonies 
on plates regardless of the presence of ampicillin indicating that these colonies 
retained pRC7uvrD as expected. In contrast, all dilutions of resuspended white 
colonies gave colonies only in the absence of ampicillin. We conclude that the small 
white colonies isolated from KM011 on 0 µM aspartate plates in (B) had indeed lost 
pRC7uvrD, confirming suppression of Δrep ΔuvrD lethality by restricting aspartate 
availability. 
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Supplementary Figure 4. Suppression of Δrep ΔuvrD lethality by restriction of amino 
acid availability is not specific to aspartate metabolism. 
The ability of a Δrep ΔuvrD ΔaspC ΔtyrB strain, KM011, to lose pRC7uvrD at 
decreasing phenylalanine concentrations on defined rich medium was assessed. 
Colony morphology was altered at lower added phenylalanine concentrations but it 
was also clear that some of these colonies were white, indicating loss of pRC7uvrD 
(compare B and C at 4 and 0 µM phenylalanine). Restriction of phenylalanine 
availability therefore reduced the need for accessory replicative helicase activity in a 
manner similar to the suppression seen upon aspartate restriction (Supplementary 
Figure 3). 
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Supplementary Table 1. Escherichia coli K12 strains.  
 
A) MG1655 derivatives 
 
MG1655 F– rph-1 (1) 
GJ6520 lacI lacZU118 trpR55 trpE9777 rho[A243E] 
Δ(yefM-yoeB)::Cm 
(2) 
JA012 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> TB28 x pAM407 to Ampr 
JA016 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr 
N6632 x pAM407 to Ampr 
JA033 pAM403 (lac+ rep+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr  Δrep::cat   
Plasmid-free segregant of 
N6644 formed on minimal 
medium subsequently 
transformed with pAM403 
to Ampr 
KM001 ΔlacIZYA::<> ΔuvrD::dhfr  
ΔaspC745::<Kan> 
P1.JW0911 x N6632 to 
Kmr 
KM003 ΔlacIZYA::<>  ΔuvrD::dhfr  ΔaspC745::<> KM001 x pCP20 (3) to 
Ampr then plasmid-free 
Kms segregant identified 
after growth on LB at 42°C 
KM005 ΔlacIZYA::<> ΔuvrD::dhfr ΔaspC745::<> 
ΔtyrB747::<kan> 
P1.JW4014 x KM003 to 
Kmr 
KM007 ΔlacIZYA::<> ΔuvrD::dhfr ΔaspC745::<> 
ΔtyrB747::<> 
KM005 x pCP20 (3) to 
Ampr then plasmid-free 
Kms segregant identified 
after growth on LB at 42°C 
KM009 pAM407 (lac+ uvrD+) / ΔlacIZYA::<> 
ΔuvrD::dhfr ΔaspC745::<> ΔtyrB747::<> 
pAM407 x KM007 to Ampr 
KM011 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr  Δrep::cat  ΔaspC745::<>  
ΔtyrB747::<> 
P1.N6577x KM009 to Cmr 
KM021 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr  tls-1 eda-51::Tn10 
P1.CS89 x N6632 to Tmr 
KM025 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr  Δrep::cat tls-1 eda-51::Tn10 
P1.N6577 x KM021 to Cmr 
KM050 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr ΔrelA782::kan 
JA016 x P1.JW2755 to 
Kmr 
KM054 pAM407 (lac+ uvrD+) / ΔlacIZYA::<> 
rpoB*35 ΔuvrD::dhfr Δrep::cat 
ΔrelA782::kan 
N7150 x P1.JW2755 to 
Kmr 
KM059 pAM407 (lac+ uvrD+) / ΔlacIZYA::<> 
ΔuvrD::dhfr Δrep::cat ΔrelA782::kan 
N6644 x P1.JW2755 to 
Kmr 
 
KM071 rpoS-mCherry::<>  rep+<kan> aspT[t8c] MG1655 RpoS-Mcherry x 
P1.LC037 to Kmr 
KM154 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr Δrep::cat  aspT[t8c] 
JA016 x P1.PM647 to 
Cmr. aspT[t8c] allele 
confirmed by sequencing 
 
KM155 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr Δrep::cat aspT[t8c] 
ΔrelA782::kan 
KM050 x P1.N7182 to Cmr 
KM189 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr  tls-1 Δeda775::kan 
KM021 x P1.JW1839 to 
Kmr and temperature-
sensitive growth. 
KM225 ΔlacIZYA::<> ΔrelA782::kan TB28 x P1.JW2755 to Kmr 
KM230 lacI lacZU118 trpR55 trpE9777 rho[A243E] 
Δ(yefM-yoeB)::Cm Δrep729::kan 
Δrep729::kan integration 
into GJ6520 using pKD46 
(4) 
KM231 ΔlacIZYA::<> rep+ <>  aspT[t8c] LC037 x pCP20 (3) to 
Ampr then plasmid-free 
Kms segregant identified 
after growth on LB at 42°C 
KM235 ΔlacIZYA::<> ΔuvrD::dhfr rep+ <kan>	
 
N6632 x P1.MKG08 to 
Kmr 
KM237 ΔlacIZYA::<> ΔuvrD::dhfr rep+<kan> 
aspT[t8c] 
N6632 x P1.LC037 to Kmr 
KM239 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr rep+ <kan>	
 
KM235 x pAM407 to Ampr 
KM240 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr rep+<kan> aspT[t8c] 
KM237 x pAM407 to Ampr 
KM241 ΔlacIZYA::<> spoT1 N7154 x pCP20 (3) to 
Ampr then plasmid-free 
Kms segregant identified 
after growth on LB at 42°C	
 
KM244 ΔlacIZYA::<> Δrep::cat spoT1 PM567 x pCP20 (3) to 
Ampr then plasmid-free 
Kms segregant identified 
after growth on LB at 42°C 
KM245 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> rep+ 
<kan> 
MKG08 x pAM407 to Ampr 
KM246 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> 
rep+<kan> aspT[t8c] 
LC037 x pAM407 to Ampr 
KM247 ΔlacIZYA::<> spoT1  rpoS-
mCherry::<kan> 
KM241 x P1. MG1655 
RpoS-Mcherry Kan to Kmr 
KM249 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr rep+ <kan> ΔruvABC::cat	
KM239 x P1.N6268 to Cmr 
KM251 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr rep+<kan> aspT[t8c] 
ΔruvABC::cat 
KM240 x P1.N6268 to Cmr 
KM253 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> rep+ 
<kan> ΔruvABC::cat 
KM245 x P1.N6268 to Cmr 
KM255 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> 
rep+<kan> aspT[t8c] ΔruvABC::cat 
KM246 x P1.N6268 to Cmr 
KM257 rpoS-mCherry::<> Δefp772::kan MG1655 RpoS-Mcherry x 
P1.JW4107 to Kmr 
KM260 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr Δrep::cat Δefp772::<> 
KM280 x P1.N6644 to Kmr 
KM268 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr Δefp772::kan 
JA016 x P1.JW4107 to 
Kmr 
KM269 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> 
rpoB*35 ΔuvrD::dhfr  Δrep729::kan 
N7150 x P1.JW5604 to 
Kmr 
KM271 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> 
rpoB*35 ΔuvrD::dhfr Δrep729::kan 
rho[A243E] 
N7150 x P1.KM230 to Kmr 
and then screening for the 
mutant rho allele by 
sequencing  
KM273 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> N6644 x P1.KM269 to Kmr 
ΔuvrD::dhfr Δrep729::kan 
KM275 pAM407 (lac+ uvrD+) / ΔlacIZYA::<> 
Δefp772::<> 
MH372 x pAM407 to Ampr 
KM277 pAM407 (lac+ uvrD+) / ΔlacIZYA::<> 
ΔuvrD::dhfr Δrep729::kan Δefp772::<>  
KM275 x P1.KM269 to 
Kmr then screened for Tmr 
KM280 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr Δefp772::<> 
Plasmid-free segregant of 
KM268 formed on LB 
subsequently transformed 
with pCP20 (3) to Ampr. 
Plasmid-free Kms 
segregant then identified 
after growth on LB at 42°C 
and then retransformed 
with pAM407 to Ampr. 
KM281 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr Δrep729::kan rho[A243E] 
N6644 x P1.KM271 to Kmr 
KM284 ΔlacIZYA::<> spoT1  rpoS-mCherry::<> KM247 x pCP20 (3) to 
Ampr then plasmid-free 
Kms segregant identified 
after growth on LB at 42°C 
KM285 rpoS-mCherry::<>  ΔrelA251::kan  
ΔspoT207::cat 
KM287 x P1.N5777 to Cmr 
KM287 rpoS-mCherry::<>  ΔrelA251::kan MG1655 RpoS-Mcherry x 
P1.N5777 to Kmr 
KM301 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr Δefp772::<> ΔrelA782::<> 
MH376 x pCP20 (3) to 
Ampr then plasmid-free 
Kms segregant identified 
after growth on LB at 
42°C. Kms strain then 
transformed with pAM407 
to Ampr and transduced 
with P1.KM189 to Tmr 
KM307 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> 
rep+<> aspT[t8c] 
KM231 x pAM407 to Ampr 
 
KM327 MG1655 ΔlacIZYA::<> ∆greA788::<kan> TB28 x P1.JW3148 to Kmr 
 
KM331 ΔlacIZYA::<> rep+<> aspT[t8c] 
∆greA788::<kan> 
KM231 x P1.JW3148 to 
Kmr 
KM335 MG1655 ΔlacIZYA::<> ∆greA::<> 
∆greB740::<kan> 
KM338 x P1.JW3369 to 
Kmr 
KM336 ΔlacIZYA::<> rep+<> aspT[t8c] 
∆greA788::<> ∆greB740::<kan> 
KM339 x P1.JW3369 to 
Kmr 
 
KM337 pAM403 (lac+ rep+) / ΔlacIZYA::<> rep+ 
<>  aspT[t8c] 
KM231 xpAM403 to Ampr 
KM338 ΔlacIZYA::<> ∆greA788::<> KM327 x pCP20 (3) to 
Ampr then plasmid-free 
Kms segregant identified 
after growth on LB at 42°C 
KM339 ΔlacIZYA::<> rep+<> aspT[t8c] 
∆greA788::<> 
KM331 x pCP20 (3) to 
Ampr then plasmid-free 
Kms segregant identified 
after growth on LB at 42°C 
KM344 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr Δrep::cat Δefp772::<> 
KM301 x P1.N6644 to Cmr 
ΔrelA782::<> 
KM346 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr Δrep729::kan aspT[t8c] 
rho[A243E] 
KM307 x P1.KM271 
KM359 pAM403 (lac+ rep+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr Δrep729::kan 
Plasmid-free segregant of 
KM273 formed on minimal 
medium subsequently 
transformed with pAM403 
to Ampr 
KM361 pAM403 (lac+ rep+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr Δrep729::kan rho[A243E] 
Plasmid-free segregant of 
KM281 formed on minimal 
medium subsequently 
transformed with pAM403 
to Ampr 
KM367 pAM403 (lac+ uvrD+) / ΔlacIZYA::<> 
ΔuvrD::dhfr Δrep729::kan Δefp772::<> 
Plasmid-free segregant of 
KM277 formed on minimal 
medium subsequently 
transformed with pAM403 
to Ampr 
KM389 pAM407 (lac+ uvrD+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr Δrep729::kan aspT[t8c] 
KM154 x P1.KM346 to 
Kmr 
KM391 pAM403 (lac+ rep+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr Δrep729::kan aspT[t8c] 
Plasmid-free segregant of 
KM389 formed on minimal 
medium subsequently 
transformed with pAM403 
to Ampr  
KM393 pAM403 (lac+ rep+) / ΔlacIZYA::<> 
Δrep729::kan Δefp772::<> rho[A243E] 
MH388 x pAM403 to 
Ampr 
KM395 pAM403 (lac+ rep+) / ΔlacIZYA::<> 
ΔuvrD::dhfr Δrep729::kan Δefp772::<> 
rho[A243E] 
KM393 x P1.KM271 to 
Tmr 
KM398 pAM403 (lac+ rep+) / ΔlacIZYA::<> 
ΔuvrD::dhfr Δrep729::kan aspT[t8c] 
rho[A243E] 
KM337 x P1.KM346 
LC037 ΔlacIZYA::<> rep+<kan> aspT[t8c] TB28 x P1.MKG121 
MG1655 
RpoS-
Mcherry 
rpoS-mCherry::<> (5) 
MG1655 
RpoS-
Mcherry 
Kan 
rpoS-mCherry::<kan> 	 Kenn Gerdes 
MH184 pAM403 (lac+ rep+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr  Δrep::cat ΔyjeA782::kan 
JA033 × P1.JW4116 to 
Kmr 
MH280 ΔlacIZYA::<> ΔyjeA782::kan TB28 × P1.JW4116 to Kmr 
MH298 pAM403 (lac+ rep+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr  Δrep::cat ΔyjeK771::kan 
JA033 × P1.JW4106 to 
Kmr 
MH299 ΔlacIZYA::<> Δefp772::kan TB28 × P1.JW4107 to Kmr 
 
MH300 ΔlacIZYA::<> Δefp772::kan TB28 × P1.JW4107 to Kmr 
MH301 pAM403 (lac+ rep+)  / ΔlacIZYA::<> 
ΔuvrD::dhfr  Δrep::cat Δefp772::kan 
JA033 × P1.JW4107 to 
Kmr 
MH303 ΔlacIZYA::<> ΔyjeK771::kan TB28 × P1.JW4106 to Kmr 
MH363 ΔlacIZYA::<> Δrep::cat ΔrelA782::kan N6577 × P1. JW2755 to 
Kmr 
 
MH364 ΔlacIZYA::<> Δefp772::kan Δrep::cat MH300 × P1.PM412 to 
Cmr 
MH372 ΔlacIZYA::<> Δefp772::<> MH299 x pCP20 (3) to 
Ampr then plasmid-free 
Kms segregant identified 
after growth on LB at 42°C 
	
 
MH374 ΔlacIZYA::<> Δefp772::<> Δrep::cat MH364 x pCP20 (3) to 
Ampr then plasmid-free 
Kms segregant identified 
after growth on LB at 42°C 
 
MH376 ΔlacIZYA::<> Δefp772::<> ΔrelA782::kan MH372 × P1. JW2755 to 
Kmr 
 
MH378 ΔlacIZYA::<> Δefp772::<> Δrep::cat 
ΔrelA782::kan 
MH374 × P1. JW2755 to 
Kmr 
 
MH388 ΔlacIZYA::<> Δrep729::kan Δefp772::<> 
rho[A243E]  
MH372 × P1.KM230 to 
Kmr then rho allele 
screened by sequencing 
MKG08 ΔlacIZYA::<> rep+ <kan> (6) 
MKG121 ΔlacIZYA::<> rep+<kan> aspT[t8c] rep+ <kan> integration into 
N8210 using pKD46 (4) 
N4304 ΔrelA251::kan  ΔspoT207::cat (7) 
N5771 ΔlacIZYA::<> ΔrelA251::kan   TB28 x P1.N4304 to Kmr 
N5777 ΔlacIZYA::<> ΔrelA251::kan  
ΔspoT207::cat 
N5771 x P1.N4304 to Cmr 
N6268 ΔlacIZYA::<> ΔruvABC::cat (8) 
N6577 ΔlacIZYA::<> Δrep::cat (9) 
N6632 ΔlacIZYA::<> ΔuvrD::dhfr (9) 
N6639 pAM407 (lac+ uvrD+) / ΔlacIZYA::<> 
ΔuvrD::dhfr 
(9) 
N6644 pAM407 (lac+ uvrD+) / ΔlacIZYA::<> 
ΔuvrD::dhfr Δrep::cat 
(9) 
N7120 ΔlacIZYA::<> ΔuvrD::dhfr Δrep::cat (9) 
N7150 pAM407 (lac+ uvrD+) / ΔlacIZYA::<> 
rpoB*35 ΔuvrD::dhfr Δrep::cat 
(9) 
N7153 ΔlacIZYA::<> rpoB*35 ΔuvrD::dhfr 
Δrep::cat 
Plasmid-free segregant of 
N7150 
N7154 ΔlacIZYA::<kan> spoT1 (9) 
N7182 ΔlacIZYA::<> ΔuvrD::dhfr Δrep::cat 
aspT[t8c] 
Isolated as a larger colony 
variant from a culture of 
N7120 grown in 56/2 
glucose medium and 
spread on LB agar 
N7187 pAM407 (lac+ uvrD+) / ΔlacIZYA::<kan> 
Δrep::cat spoT1 
(9) 
N8210 ΔlacIZYA::<> Δrep::cat aspT[t8c] P1.N7182 x TB28 to Cmr 
PM567 ΔlacIZYA::<kan> Δrep::cat spoT1 Plasmid-free segregant of 
N7187 
TB28 ΔlacIZYA::<> (10) 
 
B) Other strains 
 
BW25113 rrnB3 ΔlacZ4787 hsdR514 Δ(araBAD)567 Δ(rhaBAD)568 rph-1 (11) 
JW0911 BW25113 ΔaspC745::kan (11) 
JW1839 BW25113 Δeda775::kan (11) 
JW2755 BW25113 ΔrelA782::kan (11) 
JW3148 BW25113 ΔgreA788::kan (11) 
JW3369 BW25113 ΔgreB740::kan (11) 
JW4014 BW25113 ΔtyrB747747::kan (11) 
JW4106 BW25113 ΔyjeK771::kan (11) 
JW4107 BW25113 Δefp772::kan (11) 
JW4116 BW25113 ΔyjeA782::kan (11) 
JW5604 BW25113 Δrep729::kan (11) 
   
AB1157 araC14 thi-1 hisG4 Δ(gpt-proA)62 argE3 thr-1 leuB6 kdg51 
rfbD1 lacY1 galK2 xyl-5 mtl-1 tsx-33 supE44 rac- mgl-51 
rpsL31 qsr- 
(1) 
CS89 AB1157  tls-1  eda-51::Tn10 (12) 
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